BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30107837)

  • 1. K
    Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
    Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.
    Varga Z; Gurrola-Briones G; Papp F; Rodríguez de la Vega RC; Pedraza-Alva G; Tajhya RB; Gaspar R; Cardenas L; Rosenstein Y; Beeton C; Possani LD; Panyi G
    Mol Pharmacol; 2012 Sep; 82(3):372-82. PubMed ID: 22622363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kv1.3 channel blocker Vm24 enhances muscle glucose transporter 4 mobilization but does not reduce body-weight gain in diet-induced obese male rats.
    Jaimes-Hoy L; Gurrola GB; Cisneros M; Joseph-Bravo P; Possani LD; Charli JL
    Life Sci; 2017 Jul; 181():23-30. PubMed ID: 28549558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity.
    Csoti A; Del Carmen Nájera Meza R; Bogár F; Tajti G; Szanto TG; Varga Z; Gurrola GB; Tóth GK; Possani LD; Panyi G
    Biochem Pharmacol; 2022 May; 199():115023. PubMed ID: 35358481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.
    Tanner MR; Tajhya RB; Huq R; Gehrmann EJ; Rodarte KE; Atik MA; Norton RS; Pennington MW; Beeton C
    Clin Immunol; 2017 Jul; 180():45-57. PubMed ID: 28389388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes.
    Gurrola GB; Hernández-López RA; Rodríguez de la Vega RC; Varga Z; Batista CV; Salas-Castillo SP; Panyi G; del Río-Portilla F; Possani LD
    Biochemistry; 2012 May; 51(19):4049-61. PubMed ID: 22540187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Kv1.3 K
    Varga Z; Tajti G; Panyi G
    Biol Futur; 2021 Mar; 72(1):75-83. PubMed ID: 34554500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of three toxin peptides with Kv1.3 channel and IL-2 cytokine-inhibiting activities from Non-Buthidae scorpions, Chaerilus tricostatus and Chaerilus tryznai.
    Ding L; Chen J; Hao J; Zhang J; Huang X; Hu F; Wu Z; Liu Y; Li W; Cao Z; Wu Y; Li J; Li S; Liu H; Wu W; Chen Z
    Peptides; 2017 May; 91():13-19. PubMed ID: 28300672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
    Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
    J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
    Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
    Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
    Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
    Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
    Takacs Z; Toups M; Kollewe A; Johnson E; Cuello LG; Driessens G; Biancalana M; Koide A; Ponte CG; Perozo E; Gajewski TF; Suarez-Kurtz G; Koide S; Goldstein SA
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22211-6. PubMed ID: 20007782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway.
    Fellerhoff-Losch B; Korol SV; Ganor Y; Gu S; Cooper I; Eilam R; Besser M; Goldfinger M; Chowers Y; Wank R; Birnir B; Levite M
    J Neural Transm (Vienna); 2016 Mar; 123(3):137-57. PubMed ID: 26611796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KcsA-Kv1.x chimeras with complete ligand-binding sites provide improved predictivity for screening selective Kv1.x blockers.
    Szekér P; Bodó T; Klima K; Csóti Á; Hanh NN; Murányi J; Hajdara A; Szántó TG; Panyi G; Megyeri M; Péterfi Z; Farkas S; Gyöngyösi N; Hornyák P
    J Biol Chem; 2024 Apr; 300(4):107155. PubMed ID: 38479597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid phase synthesis, NMR structure determination of α-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity.
    Kohl B; Rothenberg I; Ali SA; Alam M; Seebohm G; Kalbacher H; Voelter W; Stoll R
    Toxicon; 2015 Jul; 101():70-8. PubMed ID: 25953725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
    Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
    J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.